|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Tracking Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| First Received Date † | January 20, 2009 | ||||||||
| Last Updated Date | January 21, 2009 | ||||||||
| Start Date † | January 2009 | ||||||||
| Current Primary Outcome Measures † |
Subjects' disease severity measured by the patient-oriented eczema measure (POEM). [ Time Frame: 3 months ] [ Designated as safety issue: No ] | ||||||||
| Original Primary Outcome Measures † | Same as current | ||||||||
| Change History | Complete list of historical versions of study NCT00826592 on ClinicalTrials.gov Archive Site | ||||||||
| Current Secondary Outcome Measures † |
Subjects'comprehension and attitude towards video-based and written education materials. [ Time Frame: 3 months ] [ Designated as safety issue: No ] | ||||||||
| Original Secondary Outcome Measures † | Same as current | ||||||||
| Descriptive Information | |||||||||
| Brief Title † | Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis | ||||||||
| Official Title † | Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis | ||||||||
| Brief Summary | The purpose of this study is to compare the effect of video-based patient education with written instruction on subjects' knowledge of atopic dermatitis and their disease severity, measured by the Patient-oriented Eczema Measure (POEM), after viewing the educational materials. |
||||||||
| Detailed Description | We plan to conduct a randomized, controlled trial comparing the effect of video-based patient education with written instruction on subjects' understanding of atopic dermatitis and their disease severity. Subjects randomized to the video-based education arm will be instructed to watch a video on the classifications, aggravating factors, and treatment of atopic dermatitis. Subjects randomized to the written education arm will receive written information on the classifications, aggravating factors, and treatment of atopic dermatitis. The contents of the video and the written educational materials will be comparable. At the end of the study period, 3 months later, subjects will be interviewed regarding their comprehension and attitude towards video-based and written education materials. Additionally, we will use the Patient-oriented Eczema Measure (POEM) questionnaire to assess the difference in subjects' disease severity between the 2 arms. |
||||||||
| Study Phase | |||||||||
| Study Type † | Interventional | ||||||||
| Study Design † | Other, Randomized, Single Blind (Investigator), Active Control, Parallel Assignment | ||||||||
| Condition † |
|
||||||||
| Intervention † | Other: Patient Educational Materials | ||||||||
| Study Arms / Comparison Groups |
|
||||||||
| Publications * | |||||||||
|
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||||||
| Recruitment Information | |||||||||
| Recruitment Status † | Recruiting | ||||||||
| Estimated Enrollment † | 84 | ||||||||
| Estimated Completion Date | December 2009 | ||||||||
| Estimated Primary Completion Date | June 2009 (final data collection date for primary outcome measure) | ||||||||
| Eligibility Criteria † | Inclusion Criteria:
Exclusion Criteria:
|
||||||||
| Gender | Both | ||||||||
| Ages | 18 Years and older | ||||||||
| Accepts Healthy Volunteers | No | ||||||||
| Contacts †† |
|
||||||||
| Location Countries † | United States | ||||||||
| Expanded Access Status | |||||||||
| Administrative Information | |||||||||
| NCT ID † | NCT00826592 | ||||||||
| Responsible Party | April W. Armstrong, MD, University of California Davis Health System | ||||||||
| Secondary IDs †† | |||||||||
| Study Sponsor † | University of California, Davis | ||||||||
| Collaborators †† | |||||||||
| Investigators † |
|
||||||||
| Information Provided By | University of California, Davis | ||||||||
| Verification Date | January 2009 | ||||||||
|
† Required WHO trial registration data element. †† WHO trial registration data element that is required only if it exists. |
|||||||||
